Posted in | News

Abengoa Bioenergy to Receive DOE’s Loan Guarantee for Biorefinery Plant Construction

The Loan Programs Office of the US Department of Energy (DOE) has selected Abengoa Bioenergy, a subsidiary of Abengoa, to offer a conditional commitment for a $133.9 million loan guarantee to build an industrial-scale biorefinery plant.

The first-of-a-kind biorefinery plant will manufacture renewable liquid fuel using the abundantly available organic feedstock such as cellulosic biomass and plant fiber as sources. With issuance of a conditional commitment by DOE, Abengoa Bioenergy has declared that it plans to begin construction of the biorefinery plant on a site located close to Hugoton, in Stephens County, Kansas.

The Chief Executive Officer at Abengoa, Manuel Sanchez stated that the company has been engineering this technology for a decade. In preparation for the Hugoton project construction, the company has engineered and fine tuned its proprietary technologies and manufactured cellulosic ethanol from the laboratory scale to a pilot biomass plant in York, Nebraska and eventually from a demonstration scale plant in Salamanca, Spain, he said.

Since 2003, DOE has been encouraging Abengoa Bioenergy's development efforts for a new ethanol manufacturing technologies. The company received $34 million for its York pilot plant through the DOE’s Office of Energy Efficiency and Renewable Energy's Biomass Program. In 2007, Abengoa Bioenergy and DOE had signed a cooperative deal to offer up to $100 million for the development of the Hugoton biomass plant.

The President and Chief Executive Officer at Abengoa Bioenergy, Javier Salgado stated that after the successful demonstration of the commercial feasibility of its proprietary enzymatic hydrolysis technology in Hugoton facility, the company will integrate the technology by incorporating cellulosic production into its current starch ethanol facilities. The Hugoton facility is also engineered to manufacture nearly 23 million gallons of superior cellulosic ethanol annually in addition to fulfilling the electrical energy of the facility.

Source: http://www.abengoa.com

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Abengoa Bioenergy to Receive DOE’s Loan Guarantee for Biorefinery Plant Construction. AZoBuild. Retrieved on November 24, 2024 from https://www.azobuild.com/news.aspx?newsID=14340.

  • MLA

    Scanlon, Joel. "Abengoa Bioenergy to Receive DOE’s Loan Guarantee for Biorefinery Plant Construction". AZoBuild. 24 November 2024. <https://www.azobuild.com/news.aspx?newsID=14340>.

  • Chicago

    Scanlon, Joel. "Abengoa Bioenergy to Receive DOE’s Loan Guarantee for Biorefinery Plant Construction". AZoBuild. https://www.azobuild.com/news.aspx?newsID=14340. (accessed November 24, 2024).

  • Harvard

    Scanlon, Joel. 2019. Abengoa Bioenergy to Receive DOE’s Loan Guarantee for Biorefinery Plant Construction. AZoBuild, viewed 24 November 2024, https://www.azobuild.com/news.aspx?newsID=14340.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.